Decongestion and acetazolamide

This forum made possible through the generous support of SDN members, donors, and sponsors. Thank you.

lymphocyte

Full Member
10+ Year Member
Joined
Feb 27, 2015
Messages
2,265
Reaction score
4,276
Really interesting trial from European Society of Cardiology. ADVOR. Adding acetazolamide 500mg IV daily + the usual IV frusemide resulted in higher rates of clinical decongestion at 3 days with no signals of harm in acute decompensated heart failure. I suspect this practice will become more widely adopted, even for garden variety ICU Michelin Man de-resuscitation. I usually reserved acetazolamide (at a higher dose) for managing alkalosis in diuresis but it might be worth giving a low dose up-front.


Members don't see this ad.
 
Last edited:
Really interesting trial from European Society of Cardiology. ADOVAR. Adding acetazolamide 500mg IV daily + the usual IV frusemide resulted in higher rates of clinical decongestion at 3 days with no signals of harm in acute decompensated heart failure. I suspect this practice will become more widely adopted, even for garden variety ICU Michelin man de-resuscitation. I usually reserved acetazolamide (at a higher dose) for managing alkalosis in diuresis but it might be worth giving a low dose up-front.


Nice I think I heard about this recently. Also interesting use of hypertonic saline with lasix was very effective and preserved Cr which is a bonus.

[/URL]
 
Members don't see this ad :)
Nice I think I heard about this recently. Also interesting use of hypertonic saline with lasix was very effective and preserved Cr which is a bonus.

[/URL]
“Hyperdiuresis” is an interesting theory with a small but growing body of evidence.

 
Maybe I’m just cynical but i find it hard to get excited about a study that basically says “two diuretics result in more diuresis than one”.

Similarly the there’s some controversy around replicatability of the hypertonic results from a particular group of authors, and if you look closely at the others they either report change in Cr as the primary outcome (is this a meaningful outcome?) or the intervention group ends up getting higher doses of diuretics plus the numbers are extremely small.

IMO we haven’t even gotten the basics right yet, which include, don’t stop diuresis because the Cr rises, use big doses of loop diuretics, add in other diuretics that actually get rid of sodium early on, and give the pt time to refill their intravascular compartment if needed.
 
Maybe I’m just cynical but i find it hard to get excited about a study that basically says “two diuretics result in more diuresis than one”.

Similarly the there’s some controversy around replicatability of the hypertonic results from a particular group of authors, and if you look closely at the others they either report change in Cr as the primary outcome (is this a meaningful outcome?) or the intervention group ends up getting higher doses of diuretics plus the numbers are extremely small.

IMO we haven’t even gotten the basics right yet, which include, don’t stop diuresis because the Cr rises, use big doses of loop diuretics, add in other diuretics that actually get rid of sodium early on, and give the pt time to refill their intravascular compartment if needed.

It's a cheap drug. No signals of harm. Two antiplatelet agents result in more antiplatelet activity than one but are not always better. Not sure why you're cynical.

The "basics" you talk about are not uncontroversial and the evidence isn't as clear cut as it is in this case, though I agree with some of those strategies.
 
Last edited:
Top